These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Remodelling of cardiac sympathetic re-innervation with thoracic spinal cord stimulation improves left ventricular function in a porcine model of heart failure. Liao SY; Liu Y; Zuo M; Zhang Y; Yue W; Au KW; Lai WH; Wu Y; Shuto C; Chen P; Siu CW; Schwartz PJ; Tse HF Europace; 2015 Dec; 17(12):1875-83. PubMed ID: 25767085 [TBL] [Abstract][Full Text] [Related]
29. Heart rate variability and its sympatho-vagal modulation. Lombardi F; Malliani A; Pagani M; Cerutti S Cardiovasc Res; 1996 Aug; 32(2):208-16. PubMed ID: 8796106 [No Abstract] [Full Text] [Related]
30. Differential effect of nicotine on plasma norepinephrine levels in normal humans and in patients with congestive heart failure. Goldsmith SR; Dodge-Brown D; Katz A; Crooks PA Am J Cardiol; 1989 Jan; 63(1):122-3. PubMed ID: 2909144 [No Abstract] [Full Text] [Related]
31. Different baseline sympathovagal balance and cardiac autonomic responsiveness in ischemic and non-ischemic congestive heart failure. Malfatto G; Branzi G; Gritti S; Sala L; Bragato R; Perego GB; Leonetti G; Facchini M Eur J Heart Fail; 2001 Mar; 3(2):197-202. PubMed ID: 11246057 [TBL] [Abstract][Full Text] [Related]
32. Alterations of cardiac sympathetic neurotransmitter activity in congestive heart failure. Rutenberg HL; Spann JF Am J Cardiol; 1973 Sep; 32(4):472-80. PubMed ID: 4147109 [No Abstract] [Full Text] [Related]
33. Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease. Adamopoulos S; Piepoli M; McCance A; Bernardi L; Rocadaelli A; Ormerod O; Forfar C; Sleight P; Coats AJ Am J Cardiol; 1992 Dec; 70(20):1576-82. PubMed ID: 1466326 [TBL] [Abstract][Full Text] [Related]
34. Plasma norepinephrine and spectral analysis of the heart rate during cardiopulmonary receptor stimulation in normal and hypertensive subjects. Rizzoni D; Castellano M; Beschi M; Muiesan ML; Bettoni G; Porteri E; Agabiti-Rosei E J Hypertens Suppl; 1991 Dec; 9(6):S84-5. PubMed ID: 1819021 [No Abstract] [Full Text] [Related]
35. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Mortara A; La Rovere MT; Signorini MG; Pantaleo P; Pinna G; Martinelli L; Ceconi C; Cerutti S; Tavazzi L Br Heart J; 1994 May; 71(5):422-30. PubMed ID: 8011405 [TBL] [Abstract][Full Text] [Related]
36. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure. Al-Hesayen A; Parker JD Circulation; 2004 Jun; 109(23):2862-5. PubMed ID: 15173026 [TBL] [Abstract][Full Text] [Related]
37. Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure. Tsutamoto T; Nishiyama K; Sakai H; Tanaka T; Fujii M; Yamamoto T; Yamaji M; Horie M Eur J Heart Fail; 2008 Dec; 10(12):1208-14. PubMed ID: 18977693 [TBL] [Abstract][Full Text] [Related]
38. Baroreceptor denervation presenting as part of a vagal mononeuropathy. Jardine DL; Melton IC; Bennett SI; Crozier IG; Donaldson IM; Ikram H Clin Auton Res; 2000 Apr; 10(2):69-75. PubMed ID: 10823338 [TBL] [Abstract][Full Text] [Related]
39. Blunted sympathetic response in diabetic patients with decompensated congestive heart failure. Burger AJ; Aronson D Int J Cardiol; 2001 Dec; 81(2-3):243-9. PubMed ID: 11744142 [TBL] [Abstract][Full Text] [Related]